Subcutaneous (SC) Mosunetuzumab (mosun) As First-Line Therapy for Patients (pts) with High Tumor-Burden Follicular Lymphoma (FL): First Results of a Multicenter Phase 2 StudyLorenzo Falchi,Michelle Okwali,Paola Ghione,Colette Owens,Paul A. Hamlin,Jennifer Kimberly Lue,Zachary D. Epstein-Peterson,Maria Lia Palomba,Anita Kumar,Pallawi Torka,Lori A. Leslie, Alexandra Ferreira Lopes, Anastasia Martinova, Lauren Wood,Clare Grieve, Walter Ramos Amador,Santosha A Vardhana,Andrew D. Zelenetz,Gilles SallesBlood（2023）引用 0|浏览7暂无评分摘要Introduction:更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
